Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
Johnson & Johnson (NYSE:JNJ) is reportedly considering selling its stroke care unit, Cerenovus, in a deal that could value ...
MassDevice10h
Johnson & Johnson reportedly wants to sell its Cerenovus stroke business for $1B
Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...
Johnson & Johnson (JNJ) Plans $1 Billion Sale of ‘Cerenovus’ Stroke Unit
Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...
Johnson & Johnson aims to sell Cerenovus for over $1 billion - Financial Times
Johnson & Johnson (NYSE:JNJ), the New Jersey-based healthcare company, is planning to sell its stroke care business, ...
Johnson & Johnson puts stroke care business up for sale
Johnson & Johnson has put its stroke care business up for sale, aiming for a valuation of more than $1bn, as part of its ...
Johnson & Johnson To Sell Cerenovus Stroke Business For $1 Billion
U.S. pharmaceutical company Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for at least $1 billion U.S. The sale is part of Johnson & Johnson’s ongoing efforts ...
J&J puts its stroke care business up for sale: report
Johnson & Johnson (NYSE:JNJ) has put its stroke care business up for sale, aiming for a valuation of more than $1B, the Financial Times reported on Tuesday, citing people familiar with the matter.